Overlooked risk for needle tract seeding following endoscopic ultrasound-guided minimally invasive tissue acquisition

World J Gastroenterol. 2020 Oct 28;26(40):6182-6194. doi: 10.3748/wjg.v26.i40.6182.

Abstract

Endoscopic ultrasound-guided minimally invasive tissue acquisition can be performed by two approaches as follows: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB). These have been evolved into leading approaches and widely used for the histological diagnosis of tumors in the gastrointestinal tract and adjacent organs. However, the role of EUS-FNA and EUS-FNB in disease diagnosis and evaluation remains controversial. Although the incidence of surgery-associated complications remains low, the consequences of needle tract seeding can be serious or even life-threatening. Recently, increasing case reports of needle tract seeding are emerging, especially caused by EUS-FNA. This complication needs serious consideration. In the present work, we integrated these case reports and the related literature, and summarized the relevant cases and technical characteristics of needle tract seeding caused by EUS-FNA and EUS-FNB. Collectively, our findings provided valuable insights into the prevention and reduction of such serious complication.

Keywords: Computed tomography; Endoscopic ultrasound-guided fine-needle aspiration; Endoscopic ultrasound-guided fine-needle biopsy; Gastrointestinal tract; Needle tract seeding.

Publication types

  • Review

MeSH terms

  • Endoscopic Ultrasound-Guided Fine Needle Aspiration* / adverse effects
  • Endosonography*
  • Humans
  • Image-Guided Biopsy
  • Needles